NASDAQ: TVRD
Tvardi Therapeutics Inc Stock Ownership - Who owns Tvardi Therapeutics?

Insider buying vs selling

Have Tvardi Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher PosnerPRESIDENT AND CEO2025-02-28583$4.75
$2.77kSell
Scott TerrillionSECY CHIEF COMPLIANCE G.C.2025-02-28163$4.76
$775.88Sell
Christopher PosnerPRESIDENT AND CEO2025-02-04372$4.72
$1.76kSell
Christopher PosnerPRESIDENT AND CEO2024-11-043,668$0.29
$1.06kSell

1 of 1

TVRD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TVRD insiders and whales buy or sell their stock.

TVRD Shareholders

What type of owners hold Tvardi Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Csl Ltd78.88%7,396,770$197.09MInsider
Vifor International Ltd78.88%7,396,770$197.09MInsider
Dean Slagel41.86%3,925,825$104.60MInsider
Rho Ventures VI LP38.05%3,568,057$95.07MInsider
Martin Vogelbaum37.10%3,479,064$92.70MInsider
Charles Phd Moller16.81%1,576,404$42.00MInsider
Derek T. Chalmers10.57%991,405$26.42MInsider
Slate Path Capital LP7.51%704,118$18.76MInstitution
Shaheen Wirk4.73%443,385$11.81MInsider
Vanguard Group Inc4.25%398,410$10.62MInstitution

1 of 3

TVRD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TVRD5.93%94.07%Net Selling
GALT11.56%88.44%Net BuyingNet Buying
NMRA26.18%73.82%Net Selling
ALLO70.14%29.86%Net SellingNet Selling
LXEO78.27%13.18%Net BuyingNet Selling

Tvardi Therapeutics Stock Ownership FAQ

Who owns Tvardi Therapeutics?

Tvardi Therapeutics (NASDAQ: TVRD) is owned by 20.74% institutional shareholders, 329.06% Tvardi Therapeutics insiders, and 0.00% retail investors. Csl Ltd is the largest individual Tvardi Therapeutics shareholder, owning 7.40M shares representing 78.88% of the company. Csl Ltd's Tvardi Therapeutics shares are currently valued at $207.48M.

If you're new to stock investing, here's how to buy Tvardi Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.